Publications in collaboration with researchers from Universidad de Valladolid (2)

2009

  1. Flow Cytometry Remission Is the Most Relevant Prognostic Factor for MM Patients Who Undergo ASCT

    CLINICAL LYMPHOMA & MYELOMA

  2. The Presence of Normal PC at Diagnosis by Flow Cytometry is a Favorable Prognostic Feature in MM

    CLINICAL LYMPHOMA & MYELOMA